Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03170141 |
Recruitment Status :
Enrolling by invitation
First Posted : May 30, 2017
Last Update Posted : January 17, 2023
|
Sponsor:
Shenzhen Geno-Immune Medical Institute
Information provided by (Responsible Party):
Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Enrolling by invitation |
---|---|
Actual Primary Completion Date : | August 1, 2020 |
Estimated Study Completion Date : | December 31, 2023 |